+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

ASH Fellow Scholar Award

American Society of Hematology

Since 1985, the ASH Scholar Award has helped ease the transition between training and the establishment of an independent career in hematology research by providing partial salary or other support during that critical period. The award offers three funding opportunities for hematology researchers. Applicants are eligible to receive the award in each level one time.

Fellow Scholar Award

Supported Research

Applicants must submit proposals to conduct research in hematology. Proposals that fall within any of the categories discussed below are encouraged:

Basic Research
Translational Research
Patient-Oriented Clinical Research
Outcomes-Based Research

AI Based Application Success Predictor

Based on ASH funding programs and funded research trends:

🥇 1. Strong Hematologic Disease Relevance (Top Predictor)

Must clearly address:
- Blood disorders
- Hematologic malignancies
- Coagulation disorders

✔ Direct link to patient outcomes is critical

🥈 2. Translational / Clinical Impact

Preference for:
- Bench-to-bedside research
- Clinical or patient-oriented studies

✔ High success:

Biomarkers
Therapeutic targets
Clinical trials

🥉 3. Innovation in Disease Mechanisms or Therapy

Funded projects often:
- Discover new pathways
- Develop novel treatments

📌 Innovation must be clinically meaningful

4. Early Career Investigator Advantage

Many ASH grants target:
- Fellows
- Junior faculty

✔ Predictor:

Strong mentorship + institutional support

5. Strong Preliminary Data (for larger awards)

Demonstrates:
- Feasibility
- Scientific rigor

✔ Especially important for:

Scholar Awards
Bridge Grants

6. Use of Human Samples / Clinical Data

Preferred:
- Patient cohorts
- Clinical datasets
- Translational models

❌ Lower priority:

Pure basic science without clinical linkage

7. Health Equity & Global Impact

Increasing priority:
- Sickle cell disease
- Global hematology disparities

✔ Projects addressing underserved populations score higher

8. Clear Study Design & Outcomes

Strong proposals include:
- Defined endpoints
- Robust methodology

🧪 Common Funded Research Areas

Leukemia & lymphoma
Sickle cell disease
Thrombosis & hemostasis
Bone marrow transplantation
Gene therapy & precision medicine
Hematologic biomarkers

⚠️ Common Reasons for Rejection

Weak hematology focus
Lack of clinical relevance
Insufficient preliminary data
Overly ambitious scope
Poor study design

🧠 Bottom Line (Key Predictors Ranked)

Direct relevance to blood disorders
Strong translational/clinical impact
Innovative yet feasible research
Mentorship (early-career grants)
Human data integration
Clear methodology and outcomes

Specialties

Hematology

Eligibility Requirements

Provides up to $100,000 over a two- to three-year period in equal quarterly payments over the award term.

Applicants must be in mentored, postdoctoral training positions to be eligible to apply for a Scholar Award. While most applicants may hold the title of fellow, holding that title is not required. Applicants with titles including, but not limited to, instructor, research associate, or staff scientist are also eligible to apply. Two mentors are required.
MD/DO or MD/DO-PhD applicants must have completed residency at least 4 years but less than 6 years prior to the letter-of-intent deadline.
- MD/DO or MD/DO-PhD who don't qualify for Scholar Fellow should apply to RTAF.
PhD or PharmD applicants must have completed their terminal doctoral degree less than 6 years prior to the letter-of-intent deadline.
Applicants who hold independent faculty level positions (Assistant Professor, or equivalent – which may be indicated by having achieved the appointment after an external search and/or if the individual has voting rights as a member of the faculty) must apply for the Junior Faculty Award, even if they are below 11 years since residency or degree. Individuals serving as an ‘acting’ faculty member may be excluded from this requirement.

Sponsor Details

Sponsor Institute/Organizations: American Society of Hematology

Sponsor Type: Corporate/Non-Profit

Address: 2021 L Street NW, Suite 900, Washington, DC 20036

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity